Metabolic Reprogramming of Sulfur in Hepatocellular Carcinoma and Sulfane Sulfur-Triggered Anti-Cancer Strategy

被引:14
|
作者
Zhang, Ximing [1 ]
Chen, Mianrong [1 ]
Ni, Xiang [2 ]
Wang, Yingying [3 ]
Zheng, Xue [1 ]
Zhang, Hui [1 ]
Xu, Shi [2 ]
Yang, Chun-tao [1 ]
机构
[1] Guangzhou Med Univ, Sch Basic Med Sci, Guangzhou Municipal & Guangdong Prov Key Lab Prot, Affiliated Canc Hosp & Inst, Guangzhou, Peoples R China
[2] Brown Univ, Dept Chem, Providence, RI 02912 USA
[3] Washington State Univ, Dept Chem, Pullman, WA 99164 USA
关键词
bioinformatics; hepatocellular carcinoma; metabolic reprogramming; reactive sulfur species; sulfane sulfur; HYDROGEN-SULFIDE; VITAMIN-B6; METABOLISM; CANCER; PROLIFERATION; BIOLOGY;
D O I
10.3389/fphar.2020.571143
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Metabolic reprogramming is a cancer hallmark. Although the reprogramming of central carbon has been well documented, the role of sulfur metabolism has been largely overlooked. Additionally, the effects of sulfur are sometimes contradictory in tumorigenesis. In this study, we aimed to investigate the gene expression profile in hepatocellular carcinoma (HCC) and the effects of reactive sulfur species (RSS) on HCC tumor cells. Furthermore, the cell imaging technology was applied to discover some potential anti-cancer compounds. Gene Set Enrichment Analysis (GSEA) of Gene Expression Omnibus (GEO) dataset (GSE102083) revealed that sulfur amino acid-related metabolism and vitamin B(6)binding activity in HCC tissues were downregulated. Calculation of the interaction network identified nine hub genes, among which eight were validated by differential expression and survival analysis in the TCGA_LIHC cohort, and two (CSE and CBS) had the highest enrichment degree. The metabolomics analysis suggested that the hub genes were associated with RSS metabolism including H2S, H2S2, cystine, cysteine, homocysteine, cystathionine, and methionine. The cell viability assay demonstrated that H(2)S(2)had significant anti-cancer effects in HCC SNU398 tumor cells. The cell imaging assay showed that treatment with H(2)S(2)remarkably increased intracellular sulfane sulfur content. On this basis, the anti-cancer activity of some other sulfane sulfur compounds, such as DATS and DADS, was further verified. Lastly, according to the fact that HCC tumor cells preferentially take in cystine due to high expression of SLC7A11 (a cystine/glutamate transporter), persulfided cysteine precursor (PSCP) was tested for its sulfane sulfur release capability and found to selectively inhibit HCC tumor cell viability. Collectively, this study uncovered sulfur metabolism in HCC was reprogrammed, and provided a potential therapeutic strategy for HCC by donating sulfane sulfur.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] The Synergistic Anti-Cancer Effects of NVP-BEZ235 and Regorafenib in Hepatocellular Carcinoma
    Yu, Cheng-Chan
    Huang, Sung-Ying
    Chang, Shu-Fang
    Liao, Kuan-Fu
    Chiu, Sheng-Chun
    MOLECULES, 2020, 25 (10):
  • [33] INHIBITION OF AUTOPHAGIC FLUX BY SALINOMYCIN RESULTS IN ANTI-CANCER EFFECT IN HEPATOCELLULAR CARCINOMA CELLS
    Klose, J.
    Stankov, M.
    Kleine, M.
    Ramackers, W.
    Jaeger, M.
    Klempnauer, J.
    Winkler, M.
    Bektas, H.
    Behrens, G.
    Vondran, F.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S82 - S82
  • [34] Extrahepatic spread from hepatocellular carcinoma: Who are candidates for aggressive anti-cancer treatment?
    Ishii, H
    Furuse, J
    Kinoshita, T
    Konishi, M
    Nakagohri, I
    Takahashi, S
    Gotohda, N
    Nakachi, K
    Yoshino, M
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2004, 34 (12) : 733 - 739
  • [36] Integrated phenotyping of the anti-cancer immune response in HIV-associated hepatocellular carcinoma
    Pinato, David J.
    Kaneko, Takahiro
    Forner, Alejandro
    Minguez, Beatriz
    Giannini, Edoardo Giovanni
    Diaz, Alba
    Grillo, Federica
    Mauri, Francesco
    Dalla Pria, Alessia
    Goldin, Robert D.
    Casagrande, Edoardo
    Cacciato, Valentina
    Akarca, Ayse
    Marafioti, Teresa
    Bhoori, Sherrie
    Bower, Mark
    Brau, Norbert
    Mazzaferro, Vincenzo
    JOURNAL OF HEPATOLOGY, 2020, 73 : S375 - S375
  • [37] IL-27 signaling regulates anti-cancer immune response in hepatocellular carcinoma
    Mazitova, Aleksandra M.
    Aghayev, Turan
    Fang, Jennifer
    Dzutsev, Amiran
    Trinchieri, Giorgio
    Campbell, Kerry S.
    Grivennikov, Sergei I.
    Koltsova, Ekaterina K.
    CANCER RESEARCH, 2022, 82 (12)
  • [38] Integrated phenotyping of the anti-cancer immune response in HIV-associated hepatocellular carcinoma
    Pinato, David J.
    Kaneko, Takahiro
    D'Alessio, Antonio
    Forner, Alejandro
    Fessas, Petros
    Minguez, Beatriz
    Giannini, Edoardo G.
    Grillo, Federica
    Diaz, Alba
    Mauri, Francesco A.
    Fulgenzi, Claudia A. M.
    Dalla Pria, Alessia
    Goldin, Robert D.
    Pieri, Giulia
    Toniutto, Pierluigi
    Avellini, Claudio
    Torres, Maria Corina Plaz
    Akarca, Ayse U.
    Marafioti, Teresa
    Bhoori, Sherrie
    Miro, Jose Maria
    Bower, Mark
    Brau, Norbert
    Mazzaferro, Vincenzo
    JHEP REPORTS, 2023, 5 (07)
  • [39] Inhibition of Autophagic Flux by Salinomycin Results in Anti-Cancer Effect in Hepatocellular Carcinoma Cells
    Klose, Johannes
    Stankov, Metodi V.
    Kleine, Moritz
    Ramackers, Wolf
    Panayotova-Dimitrova, Diana
    Jaeger, Mark D.
    Klempnauer, Juergen
    Winkler, Michael
    Bektas, Hueseyin
    Behrens, Georg M. N.
    Vondran, Florian W. R.
    PLOS ONE, 2014, 9 (05):
  • [40] Chemical Properties and Mechanisms Determining the Anti-Cancer Action of Garlic-Derived Organic Sulfur Compounds
    Cerella, Claudia
    Dicato, Mario
    Jacob, Claus
    Diederich, Marc
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2011, 11 (03) : 267 - 271